Expression Profiling of EWS/FLI Identifies NKX2.2 as a Critical Target Gene in Ewing's Sarcoma (DOI:10.1016/j.ccr.2006.04.004);Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma

Cancer Cell

Volumn 9, Issue 5, 2006, Pages 405-416

  Smith, Richard ^a   Owen, Leah A ^b   Trem, Deborah J ^a   Wong, Jenny S ^c   Whangbo, Jennifer S ^c   Golub, Todd R ^c,d   Lessnick, Stephen L ^a,b  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN;

ARTICLE; CONTROLLED STUDY; EWING SARCOMA; FUNCTIONAL ASSESSMENT; GENE CONTROL; GENE IDENTIFICATION; GENE TARGETING; HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; RNA INTERFERENCE; TRANSCRIPTION INITIATION; TUMOR CELL;

EID: 33646366123     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2006.12.009     Document Type: Erratum

References (48)

1. Ambros I.M., Ambros P.F., Strehl S., Kovar H., Gadner H., and Salzer-Kuntschik M. MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration. Cancer 67 (1991) 1886-1893
2. Arvand A., Bastians H., Welford S.M., Thompson A.D., Ruderman J.V., and Denny C.T. EWS/FLI1 up regulates mE2-C, a cyclin-selective ubiquitin conjugating enzyme involved in cyclin B destruction. Oncogene 17 (1998) 2039-2045
3. Arvand A., Welford S.M., Teitell M.A., and Denny C.T. The COOH-terminal domain of FLI-1 is necessary for full tumorigenesis and transcriptional modulation by EWS/FLI-1. Cancer Res. 61 (2001) 5311-5317
4. Bailly R.A., Bosselut R., Zucman J., Cormier F., Delattre O., Roussel M., Thomas G., and Ghysdael J. DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma. Mol. Cell. Biol. 14 (1994) 3230-3241
5. Baird K., Davis S., Antonescu C.R., Harper U.L., Walker R.L., Chen Y., Glatfelter A.A., Duray P.H., and Meltzer P.S. Gene expression profiling of human sarcomas: insights into sarcoma biology. Cancer Res. 65 (2005) 9226-9235
6. Braun B.S., Frieden R., Lessnick S.L., May W.A., and Denny C.T. Identification of target genes for the Ewing's sarcoma EWS/FLI fusion protein by representational difference analysis. Mol. Cell. Biol. 15 (1995) 4623-4630
7. Briscoe J., Sussel L., Serup P., Hartigan-O'Connor D., Jessell T.M., Rubenstein J.L., and Ericson J. Homeobox gene Nkx2.2 and specification of neuronal identity by graded Sonic hedgehog signaling. Nature 398 (1999) 622-627
8. Cavenzzana A.O., Miser J.S., Jefferson J., and Triche T.J. Experimental evidence for a neural origin of Ewing's sarcoma of bone. Am. J. Pathol. 127 (1987) 507-518
9. Choi Y.L., Chi J.G., and Suh Y.L. CD99 immunoreactivity in ependymoma. Appl. Immunohistochem. Mol. Morphol. 9 (2001) 125-129
10. Collini P., Mezzelani A., Modena P., Dagrada P., Tamborini E., Luksch R., Gronchi A., Navarria P., Sozzi G., and Pilotti S. Evidence of neural differentiation in a case of post-therapy primitive neuroectodermal tumor/Ewing sarcoma of bone. Am. J. Surg. Pathol. 27 (2003) 1161-1166
11. Dauphinot L., De Oliveira C., Melot T., Sevenet N., Thomas V., Weissman B.E., and Delattre O. Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2and c-Myc expression. Oncogene 20 (2001) 3258-3265
12. Delattre O., Zucman J., Plougastel B., Desmaze C., Melot T., Peter M., Heinrich K., Houbert I., de Jong P., Rouleau G., et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359 (1992) 162-165
13. Deneen B., and Denny C.T. Loss of p16 pathways stabilizes EWS/FLI1 expression and complements EWS/FLI1 mediated transformation. Oncogene 20 (2001) 6731-6741
14. Deneen B., Hamidi H., and Denny C.T. Functional analysis of the EWS/ETS target gene uridine phosphorylase. Cancer Res. 63 (2003) 4268-4274
15. Dworzak M.N., Fritsch G., Buchinger P., Fleischer C., Printz D., Zellner A., Schollhammer A., Steiner G., Ambros P.F., and Gadner H. Flow cytometric assessment of human MIC2 expression in bone marrow, thymus, and peripheral blood. Blood 83 (1994) 415-425
16. Fukuma M., Okita H., Hata J., and Umezawa A. Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma. Oncogene 22 (2003) 1-9
17. Hahm K.B., Cho K., Lee C., Im Y.H., Chang J., Choi S.G., Sorensen P.H., Thiele C.J., and Kim S.J. Repression of the gene encoding the TGF-β type II receptor is a major target of the EWS-FLI1 oncoprotein. Nat. Genet. 23 (1999) 222-227
18. Hu-Lieskovan S., Heidel J.D., Bartlett D.W., Davis M.E., and Triche T.J. Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma. Cancer Res. 65 (2005) 8984-8992
19. Hu-Lieskovan S., Zhang J., Wu L., Shimada H., Schofield D.E., and Triche T.J. EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors. Cancer Res. 65 (2005) 4633-4644
20. Huppi K., Martin S.E., and Caplen N.J. Defining and assaying RNAi in mammalian cells. Mol. Cell 17 (2005) 1-10
21. Jackson A.L., Bartz S.R., Schelter J., Kobayashi S.V., Burchard J., Mao M., Li B., Cavet G., and Linsley P.S. Expression profiling reveals off-target gene regulation by RNAi. Nat. Biotechnol. 21 (2003) 635-637
22. Jain M., Arvanitis C., Chu K., Dewey W., Leonhardt E., Trinh M., Sundberg C.D., Bishop J.M., and Felsher D.W. Sustained loss of a neoplastic phenotype by brief inactivation of MYC. Science 297 (2002) 102-104
23. Jaishankar S., Zhang J., Roussel M.F., and Baker S.J. Transforming activity of EWS/FLI is not strictly dependent upon DNA-binding activity. Oncogene 18 (1999) 5592-5597
24. Khan J., Wei J.S., Ringner M., Saal L.H., Ladanyi M., Westermann F., Berthold F., Schwab M., Antonescu C.R., Peterson C., and Meltzer P.S. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat. Med. 7 (2001) 673-679
25. Kim Y., and Nirenberg M. Drosophila NK-homeobox genes. Proc. Natl. Acad. Sci. USA 86 (1989) 7716-7720
26. Lessnick S.L., Braun B.S., Denny C.T., and May W.A. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI- 1 fusion gene. Oncogene 10 (1995) 423-431
27. Lessnick S.L., Dacwag C.S., and Golub T.R. The Ewing's sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts. Cancer Cell 1 (2002) 393-401
28. Masutomi K., Yu E.Y., Khurts S., Ben-Porath I., Currier J.L., Metz G.B., Brooks M.W., Kaneko S., Murakami S., DeCaprio J.A., et al. Telomerase maintains telomere structure in normal human cells. Cell 114 (2003) 241-253
29. Matias-Guiu X., Pons C., and Prat J. Mullerian inhibiting substance, α-inhibin, and CD99 expression in sex cord-stromal tumors and endometrioid ovarian carcinomas resembling sex cord-stromal tumors. Hum. Pathol. 29 (1998) 840-845
30. May W.A., Arvand A., Thompson A.D., Braun B.S., Wright M., and Denny C.T. EWS/FLI1-induced manic fringe renders NIH 3T3 cells tumorigenic. Nat. Genet. 17 (1997) 495-497
31. May W.A., Gishizky M.L., Lessnick S.L., Lunsford L.B., Lewis B.C., Delattre O., Zucman J., Thomas G., and Denny C.T. Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc. Natl. Acad. Sci. USA 90 (1993) 5752-5756
32. May W.A., Lessnick S.L., Braun B.S., Klemsz M., Lewis B.C., Lunsford L.B., Hromas R., and Denny C.T. The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol. Cell. Biol. 13 (1993) 7393-7398
33. McMahon A.P. Neural patterning: the role of Nkx genes in the ventral spinal cord. Genes Dev. 14 (2000) 2261-2264
34. Mootha V.K., Lindgren C.M., Eriksson K.F., Subramanian A., Sihag S., Lehar J., Puigserver P., Carlsson E., Ridderstrale M., Laurila E., et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34 (2003) 267-273
35. Mu J., Skurat A.V., and Roach P.J. Glycogenin-2, a novel self-glucosylating protein involved in liver glycogen biosynthesis. J. Biol. Chem. 272 (1997) 27589-27597
36. Navas-Palacios J.J., Aparicio-Duque R., and Valdes M.D. On the histogenesis of Ewing's sarcoma. An ultrastructural, immunohistochemical, and cytochemical study. Cancer 53 (1984) 1882-1901
37. Price M., Lazzaro D., Pohl T., Mattei M.G., Ruther U., Olivo J.C., Duboule D., and Di Lauro R. Regional expression of the homeobox gene Nkx-2.2 in the developing mammalian forebrain. Neuron 8 (1992) 241-255
38. Prieur A., Tirode F., Cohen P., and Delattre O. EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3. Mol. Cell. Biol. 24 (2004) 7275-7283
39. Qi Y., Cai J., Wu Y., Wu R., Lee J., Fu H., Rao M., Sussel L., Rubenstein J., and Qiu M. Control of oligodendrocyte differentiation by the Nkx2.2 homeodomain transcription factor. Development 128 (2001) 2723-2733
40. Rubin J.B., Kung A.L., Klein R.S., Chan J.A., Sun Y., Schmidt K., Kieran M.W., Luster A.D., and Segal R.A. A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc. Natl. Acad. Sci. USA 100 (2003) 13513-13518
41. Schenkel A.R., Mamdouh Z., Chen X., Liebman R.M., and Muller W.A. CD99 plays a major role in the migration of monocytes through endothelial junctions. Nat. Immunol. 3 (2002) 143-150
42. Staege M.S., Hutter C., Neumann I., Foja S., Hattenhorst U.E., Hansen G., Afar D., and Burdach S.E. DNA microarrays reveal relationship of Ewing family tumors to both endothelial and fetal neural crest-derived cells and define novel targets. Cancer Res. 64 (2004) 8213-8221
43. Teitell M.A., Thompson A.D., Sorensen P.H., Shimada H., Triche T.J., and Denny C.T. EWS/ETS fusion genes induce epithelial and neuroectodermal differentiation in NIH 3T3 fibroblasts. Lab. Invest. 79 (1999) 1535-1543
44. Thompson A.D., Braun B.S., Arvand A., Stewart S.D., May W.A., Chen E., Korenberg J., and Denny C. EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FLI1 fusion gene. Oncogene 13 (1996) 2649-2658
45. Thompson A.D., Teitell M.A., Arvand A., and Denny C.T. Divergent Ewing's sarcoma EWS/ETS fusions confer a common tumorigenic phenotype on NIH3T3 cells. Oncogene 18 (1999) 5506-5513
46. Welford S.M., Hebert S.P., Deneen B., Arvand A., and Denny C.T. DNA binding domain independent pathways are involved in EWS/FLI1 mediated oncogenesis. J. Biol. Chem. 276 (2001) 41977-41984
47. Zhang H., Herbert B.S., Pan K.H., Shay J.W., and Cohen S.N. Disparate effects of telomere attrition on gene expression during replicative senescence of human mammary epithelial cells cultured under different conditions. Oncogene 23 (2004) 6193-6198
48. Zwerner J.P., and May W.A. PDGF-C is an EWS/FLI induced transforming growth factor in Ewing family tumors. Oncogene 20 (2001) 626-633